Unified Patents Keeps Win Over Email Filtering IP At Fed. Circ.

Thursday, March 26, 2026iiplaeditorialSource: IIPLA
unified-patents-keeps-win-over-email-fil.png
Source attribution
Image: Image courtesy of iipla.org

Unified Patents Keeps Win Over Email Filtering IP At Fed. Circ.

By Editorial Team

The Federal Circuit has upheld a decision not to reinstate claims in an email filtering patent challenged by Unified Patents. The court backed the Patent Trial and Appeal Board's ruling that previous inventions had made the claims invalid.

Unified Patents, a prominent player in challenging patents, faced off against the email filtering patent in question. The Federal Circuit's decision affirms the PTAB's determination that the patent claims were no longer valid due to earlier inventions.

The case involved the patent number 6,965,920, titled "Profile responsive electronic message management system." Notable entities involved in the legal battle include Google LLC and Microsoft Corp.

The ruling by the Federal Circuit marks a significant development in the ongoing legal landscape surrounding intellectual property rights and patent challenges. The decision sets a precedent for future cases involving similar patent disputes.

For more details on this case and its implications, legal professionals can access the full opinion document attached to the article.

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026